WEST PHARMACEUTICAL SERVICES INC - Director's Dealing 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-10-31

Reporting Person: Witherspoon Charles (VP & Treasurer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-31	Common Stock	M	594	$173.22	Acquired	2429.091	Direct
2023-10-31	Common Stock	M	596	$274.29	Acquired	3025.091	Direct
2023-10-31	Common Stock	S	594	$322.475	Disposed	2431.091	Direct
2023-10-31	Common Stock	S	596	$322.27	Disposed	1835.091	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-31	Stock Options (Right to Buy)	$173.22	M	594	Disposed	2030-02-18	Stock Options (Right to Buy) (594)	Direct
2023-10-31	Stock Options (Right to Buy)	$274.29	M	596	Disposed	2031-02-23	Stock Options (Right to Buy) (596)	Direct

F1: This award vests in four equal annual installments beginning on February 18, 2021.

F2: This award vests in four equal annual installments beginning on February 23, 2022.